BioSpace News Archive

Drug Development

Paratek Pharmaceuticals Presents Data Supporting Potential Approval of Omadacycline for Treatment of Community-Acquired Bacterial Pneumonia Based on the EMA Guidelines at ECCMID

Paratek Pharmaceuticals, Inc. presented an analysis of data from the Company’s Phase 3 OPTIC study of omadacycline vs. moxifloxacin for the treatment of community-acquired bacterial pneumonia (CABP) using the European Medicines Agency (EMA) guidance for approval of new treatments for CABP.

April 24, 2018
·
6 min read
Drug Development

GNI Group Initiates Phase I Study of F351 in USA

GNI USA, Inc announced the first subject was dosed in the F351 Phase I clinical trial taking place in New Jersey, USA.

April 24, 2018
·
1 min read
Drug Development

Tocagen Granted ApolloBio Greater China Rights of Immunotherapy Candidate for $127 Million

Tocagen Inc. licensed its Phase III stage candidate Toca 511 & Toca FC to ApolloBio .

April 24, 2018
·
1 min read
Drug Development

Paratek Pharmaceuticals Presents New Microbiology Efficacy Data of Oral-only Omadacycline Against the Most Common Pathogens Associated with Skin Infections

Paratek Pharmaceuticals, Inc. announced that an analysis of microbiology data from OASIS-2, its second Phase 3 study of omadacycline in acute skin infections, found that once-daily monotherapy with oral omadacycline is effective in treating frequently isolated pathogens associated with skin infections, including resistant Staphylococcus aureus (MRSA).

April 24, 2018
·
6 min read
Business

Xellia Pharmaceuticals Appoints Craig Boyd as President, Xellia US as it Expands its Commercial Organization in Preparation for the Launch of its Value-Added Anti-Infective Drug Products

Xellia Pharmaceuticals announced that it has appointed Craig Boyd to the new leadership role of President, Xellia US.

April 24, 2018
·
4 min read
FDA

Medtronic IN.PACT(TM) Admiral(TM) Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions

New Indication Expands DCB Treatment for Patients with SFA Lesions Up to 360mm

April 24, 2018
·
4 min read
Bruker Introduces Contour LS-K 3D Optical Profiler

Bruker announced the release of its new Contour LS-K 3D optical profiler with LightSpeed™ focus variation technology.

April 24, 2018
·
3 min read